M. M. E. Schneider

2.4k total citations
39 papers, 1.7k citations indexed

About

M. M. E. Schneider is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, M. M. E. Schneider has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 17 papers in Infectious Diseases and 7 papers in Virology. Recurrent topics in M. M. E. Schneider's work include HIV/AIDS drug development and treatment (10 papers), Pneumonia and Respiratory Infections (9 papers) and HIV Research and Treatment (7 papers). M. M. E. Schneider is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), Pneumonia and Respiratory Infections (9 papers) and HIV Research and Treatment (7 papers). M. M. E. Schneider collaborates with scholars based in Netherlands, United Kingdom and Germany. M. M. E. Schneider's co-authors include Andy I. M. Hoepelman, Jan C.C. Borleffs, Jan Jelrik Oosterheert, Marc J. M. Bonten, I. M. Hoepelman, Jan Karel M. Eeftinck Schattenkerk, Eelko Hak, Ronald P. Stolk, C. A. J. J. Jaspers and Jan M. Prins and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Clinical Infectious Diseases.

In The Last Decade

M. M. E. Schneider

39 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. M. E. Schneider Netherlands 20 934 774 278 266 145 39 1.7k
S. Alfandari France 22 1.0k 1.1× 951 1.2× 344 1.2× 207 0.8× 191 1.3× 112 2.1k
Kathleen A. Steger United States 19 624 0.7× 519 0.7× 585 2.1× 165 0.6× 115 0.8× 29 1.7k
Bruce H. Hamory United States 21 537 0.6× 469 0.6× 160 0.6× 45 0.2× 77 0.5× 54 1.6k
Christian Rabaud France 25 1.0k 1.1× 720 0.9× 103 0.4× 193 0.7× 132 0.9× 104 2.1k
Prakash Jeena South Africa 26 1.0k 1.1× 790 1.0× 88 0.3× 239 0.9× 254 1.8× 93 2.0k
David T. Kuhar United States 21 512 0.5× 990 1.3× 104 0.4× 57 0.2× 51 0.4× 45 1.9k
Meryl H. Mendelson United States 23 695 0.7× 703 0.9× 118 0.4× 40 0.2× 76 0.5× 46 1.6k
Gail L. Levine United States 12 438 0.5× 222 0.3× 357 1.3× 48 0.2× 89 0.6× 17 1.1k
Thomas W. Barber Australia 20 1.1k 1.1× 683 0.9× 223 0.8× 22 0.1× 89 0.6× 40 2.1k
Jeffrey Glassroth United States 28 2.6k 2.8× 2.0k 2.6× 75 0.3× 155 0.6× 324 2.2× 61 3.7k

Countries citing papers authored by M. M. E. Schneider

Since Specialization
Citations

This map shows the geographic impact of M. M. E. Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. M. E. Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. M. E. Schneider more than expected).

Fields of papers citing papers by M. M. E. Schneider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. M. E. Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. M. E. Schneider. The network helps show where M. M. E. Schneider may publish in the future.

Co-authorship network of co-authors of M. M. E. Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of M. M. E. Schneider. A scholar is included among the top collaborators of M. M. E. Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. M. E. Schneider. M. M. E. Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boselie, Paul, et al.. (2018). Using regulatory enforcement theory to explain compliance with quality and patient safety regulations: the case of internal audits. BMC Health Services Research. 18(1). 62–62. 16 indexed citations
2.
Rensen, Elizabeth L. J. van, et al.. (2015). Medisch leiderschap ontrafeld. Utrecht University Repository (Utrecht University). 4 indexed citations
3.
Hofstra, L. Marije, Monique Nijhuis, Tania Mudrikova, et al.. (2014). Use of dolutegravir in two INI‐experienced patients with multiclass resistance resulted in excellent virological and immunological responses. Journal of the International AIDS Society. 17(4S3). 19755–19755. 3 indexed citations
4.
Zaal, Irene J., Linda M. Peelen, Maarten M. J. van Eijk, et al.. (2012). Intensive care unit environment may affect the course of delirium. Intensive Care Medicine. 39(3). 481–488. 72 indexed citations
5.
Schneider, M. M. E. & Wolfgang Schramm. (2010). [A quarter century of psychosocial haemophilia-counseling].. PubMed. 30 Suppl 1. S19–22. 2 indexed citations
6.
Rothová, Aniki, M. M. E. Schneider, & Jolanda D.F. de Groot-Mijnes. (2008). Human Immunodeficiency Virus-induced Uveitis: Intraocular and Plasma Human Immunodeficiency Virus-1 RNA Loads. Ophthalmology. 115(11). 2062–2064. 18 indexed citations
7.
Radtke, Finn M., Martin Franck, M. M. E. Schneider, et al.. (2008). Comparison of three scores to screen for delirium in the recovery room. British Journal of Anaesthesia. 101(3). 338–343. 102 indexed citations
8.
9.
Oosterheert, Jan Jelrik, Marc J. M. Bonten, M. M. E. Schneider, et al.. (2006). Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ. 333(7580). 1193–1193. 129 indexed citations
10.
Oosterheert, Jan Jelrik, Anton M. van Loon, Rob Schuurman, et al.. (2005). Impact of Rapid Detection of Viral and Atypical Bacterial Pathogens by Real-Time Polymerase Chain Reaction for Patients with Lower Respiratory Tract Infection. Clinical Infectious Diseases. 41(10). 1438–1444. 152 indexed citations
11.
Oosterheert, Jan Jelrik, Marc J. M. Bonten, M. M. E. Schneider, & I. M. Hoepelman. (2005). Predicted effects on antibiotic use following the introduction of British or North American guidelines for community-acquired pneumonia in The Netherlands. Clinical Microbiology and Infection. 11(12). 992–998. 9 indexed citations
12.
Burger, David M., Patricia W. H. Hugen, Peter Reiss, et al.. (2003). Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals. AIDS. 17(8). 1157–1165. 119 indexed citations
13.
Oosterheert, Jan Jelrik, Marc J. M. Bonten, Eelko Hak, M. M. E. Schneider, & Andy I. M. Hoepelman. (2003). Severe community-acquired pneumonia: whatʼs in a name?. Current Opinion in Infectious Diseases. 16(2). 153–159. 22 indexed citations
14.
Ledergerber, Bruno, Amanda Mocroft, Peter Reiss, et al.. (2001). Discontinuation of Secondary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy. New England Journal of Medicine. 344(3). 168–174. 109 indexed citations
15.
Schneider, M. M. E., Jan C.C. Borleffs, Ronald P. Stolk, C. A. J. J. Jaspers, & Andy I. M. Hoepelman. (1999). Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy. The Lancet. 353(9148). 201–203. 126 indexed citations
16.
Borleffs, Jan C.C., et al.. (1998). Effect of escalating doses of recombinant human granulocyte colony—stimulating factor (filgrastim) on circulating neutrophils in healthy subjects. Clinical Therapeutics. 20(4). 722–736. 41 indexed citations
17.
Schneider, M. M. E., M Sprenger, I. M. Hoepelman, Yolanda van der Graaf, & Jan C.C. Borleffs. (1996). Antibody response to tetravalent influenza subunit vaccine in patients infected with human immunodeficiency virus type 1. International Journal of Antimicrobial Agents. 6(4). 195–200. 6 indexed citations
18.
Hoepelman, I. M. & M. M. E. Schneider. (1995). Azithromycin: the first of the tissue-selective azalides. International Journal of Antimicrobial Agents. 5(3). 145–167. 58 indexed citations
19.
Schneider, M. M. E., et al.. (1995). Efficacy and Toxicity of Two Doses of Trimethoprim-Sulfamethoxazole as Primary Prophylaxis against Pneumocystis carinii Pneumonia in Patients with Human Immunodeficiency Virus. The Journal of Infectious Diseases. 171(6). 1632–1636. 50 indexed citations
20.
Schneider, M. M. E., Andy I. M. Hoepelman, Jan Karel M. Eeftinck Schattenkerk, et al.. (1992). A Controlled Trial of Aerosolized Pentamidine or Trimethoprim–Sulfamethoxazole as Primary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with Human Immunodeficiency Virus Infection. New England Journal of Medicine. 327(26). 1836–1841. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Alfandari Breakdown of academic impact, for papers by Kathleen A. Steger Breakdown of academic impact, for papers by Bruce H. Hamory Breakdown of academic impact, for papers by Christian Rabaud Breakdown of academic impact, for papers by Prakash Jeena Breakdown of academic impact, for papers by David T. Kuhar Breakdown of academic impact, for papers by Meryl H. Mendelson Breakdown of academic impact, for papers by Gail L. Levine Breakdown of academic impact, for papers by Thomas W. Barber Breakdown of academic impact, for papers by Jeffrey Glassroth
Rankless by CCL
2026